Skip to main content
NIH funding notice PAR-19-351

Limited Competition: Exploratory and Developmental Research Grant Program for NIAID K01/K08/K23 Recipients (R21 Clinical Trial Not Allowed)

Closed on September 7, 2020.

Posted
August 20, 2019
Close date
September 7, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

9 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,092,544 in first-year total cost, median $225,203.

Most frequent study sections

  1. Population and Public Health Approaches to HIV/AIDS Study Section[PPAH]2
  2. Clinical Management of Patients in Community-based Settings Study Section[CMPC]1
  3. Hypersensitivity, Autoimmune, and Immune-mediated Diseases Study Section[HAI]1
  4. Immunity and Host Defense Study Section[IHD]1
  5. Infectious Diseases, Reproductive Health, Asthma and Pulmonary Conditions Study Section[IRAP]1

Most frequent institutions

  1. UNIVERSITY OF WASHINGTON2
  2. ARKANSAS CHILDREN'S HOSPITAL RES INST1
  3. BRIGHAM AND WOMEN'S HOSPITAL1
  4. CHILDREN'S HOSP OF PHILADELPHIA1
  5. COLUMBIA UNIVERSITY HEALTH SCIENCES1
Competing awards under PAR-19-351 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2021Investigating gene regulatory networks in immune cells of children who differ in susceptibility to malaria infection using single-cell approaches1R21AI156443-01TRAN, TUAN MANHINDIANA UNIVERSITY INDIANAPOLIS, IN$317,000IHD
2021Metabolomic Prediction of Pneumonia Severity1R21AI154239-01A1AMBROGGIO, LILLIAMUNIVERSITY OF COLORADO DENVER, CO$233,250IRAP
2021Brush cell sensing of aeroallergen-elicited stress signals promotes epithelial cell activation1R21AI154345-01A1BANKOVA, LORABRIGHAM AND WOMEN'S HOSPITAL, MA$225,203LCMI
2021ORMDL3 Stimulated ICAM1 and RVA-induced Childhood Asthma Exacerbations1R21AI156446-01KENNEDY, JOSHUAARKANSAS CHILDREN'S HOSPITAL RES INST, AR$215,859ZRG1
2021Addressing the burden of untreated HIV in cancer patients in sub-Saharan Africa: feasibility and planning for a pragmatic clinical trial1R21AI155055-01A1BENDER IGNACIO, RACHEL ANNUNIVERSITY OF WASHINGTON, WA$162,402PPAH
2020Leveraging Agriculture and Uniting Communities to Improve HIV Outcomes in Senegal1R21AI154990-01BENZEKRI, NOELLE ANGELINAUNIVERSITY OF WASHINGTON, WA$267,313PPAH
2020Leveraging humoral immunity to promote commensal microbial protection from T1D1R21AI153956-01SILVERMAN, MICHAEL ACHILDREN'S HOSP OF PHILADELPHIA, PA$264,000HAI
2020Breast milk microbiome in relation to maternal helminth infection status1R21AI148758-01A1MCDONALD, EMILY ARHODE ISLAND HOSPITAL, RI$212,105ZRG1
2020Flexible InteRvention Strategy for TB prevention (FIRST) study1R21AI153954-01HIRSCH-MOVERMAN, YAEL RCOLUMBIA UNIVERSITY HEALTH SCIENCES, NY$195,412CMPC

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-19-351: Limited Competition: Exploratory and Developmental Research Grant Program for NIAID K01/K08/K23 Recipients (R21 Clinical Trial Not Allowed) | ScienceDex | ConductScience